2026 NPPES data Oncology Pharmacist NPI 1932655693 PHARM.D
Verify on CMS →

DAZHI LIU, PHARM.D

Oncology Pharmacist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
79
Medicare Part D claims · 22 beneficiaries · Oncology Pharmacist avg: 160
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: DAZHI LIU, PHARM.D is a Oncology Pharmacist ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 79 claims across 22 beneficiaries — 46% brand-name prescribing .

What stands out: DAZHI LIU, PHARM.D filed 79 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

DAZHI LIU, PHARM.D at a glance

Quality data not reported

NPI registry status

Active

Issued 08/31/2016

NPI 1932655693

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Medicare Part D claims

79 51% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in New York

How Oncology Pharmacist compares to other specialties among New York providers

New York providers

Oncology Pharmacist share within New York

1. Oncology Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Pharmacist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Pharmacist ABMS/AOA estimate

Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAZHI LIU, PHARM.D is a Oncology Pharmacist provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM.D. NPI: 1932655693. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAZHI LIU, PHARM.D appears in the CMS NPPES registry as a Oncology Pharmacist provider holding PHARM.D credentials at 1275 YORK AVE, NEW YORK, NY, 10065, with a listed phone of (609) 480-6497. NPI 1932655693 was issued on 08/31/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LIU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 79 prescription claims written by this provider, covering 22 Medicare beneficiaries and totaling roughly $17K in drug spend, split 46% brand-name and 54% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1275 YORK AVE
NEW YORK, NY 10065

Provider Details

NPI 1932655693
Specialty Oncology Pharmacist
Credentials PHARM.D
Gender Female
NPI Issued 08/31/2016

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DAZHI LIU, PHARM.D. To verify DAZHI LIU, PHARM.D's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

DAZHI LIU, PHARM.D — brand share 46.0%
Specialty average (est.)

46% brand-name claims vs 54% generic, on 79 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

79
Total Claims
$17K
Total Drug Cost
22
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
113
Total Day Supply
3,329
Brand vs Generic
46% brand / 54% generic
Brand Drug Cost
$16K
Generic Drug Cost
$398

Patient Demographics

Average Patient Age
71.0 years
Avg HCC Risk Score
2.84

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Xarelto
Rivaroxaban
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Pharmacist Overview

How DAZHI LIU, PHARM.D fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

DAZHI LIU, PHARM.D's 79 claims are below the specialty average of 160.

Nearby Oncology Pharmacist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LIU.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAZHI LIU, PHARM.D's specialty?
DAZHI LIU, PHARM.D specializes in Oncology Pharmacist and practices in NEW YORK, New York. Credentials: PHARM.D.
How much does DAZHI LIU, PHARM.D prescribe under Medicare Part D?
In 2023, DAZHI LIU, PHARM.D wrote 79 Medicare Part D claims totaling $17K in drug costs for 22 beneficiaries.
Where is DAZHI LIU, PHARM.D located?
DAZHI LIU, PHARM.D is located at 1275 YORK AVE, NEW YORK, NY, 10065. Phone: (609) 480-6497.
What is DAZHI LIU, PHARM.D's NPI number?
DAZHI LIU, PHARM.D's National Provider Identifier (NPI) is 1932655693, issued on 08/31/2016.
Does DAZHI LIU, PHARM.D prescribe more brand-name or generic drugs?
DAZHI LIU, PHARM.D's prescribing is 46% brand-name and 54% generic drugs by claim count, with $16K in brand drug costs.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
What drugs does DAZHI LIU, PHARM.D prescribe most often?
Based on 2023 Medicare Part D data, DAZHI LIU, PHARM.D's most frequently prescribed drugs include Xarelto. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAZHI LIU, PHARM.D accept Medicare?
DAZHI LIU, PHARM.D appears in CMS Medicare data with 79 Part D claims and 22 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAZHI LIU, PHARM.D's credentials?
DAZHI LIU, PHARM.D's NPI is 1932655693 with credentials PHARM.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology